RENTOX 200U

ReNTox™ 200 Units is a next-generation, premium-class botulinum toxin type A product developed by Pharma Research Bio, a leading South Korean pharmaceutical company. It is presented as a lyophilized white powder for injection, contained in a clear, colorless vial. This preparation is designed for both aesthetic and therapeutic use, offering a low-diffusion, high-stability profile with fast onset and extended efficacy. Indications ReNTox™ is indicated for the treatment of: Imitation (dynamic) wrinkles Blepharospasm (eyelid spasm) Hemifacial spasm Cervical dystonia (spastic torticollis) Focal spasticity of the wrist and hand in post-stroke patients Paralytic strabismus Localized muscle spasticity in children with cerebral palsy (ages 2+)   Benefits 3D Effect: Clinical effects typically begin within 3 days of administration and may last 6 to 8 months. Advanced Composition: Formulated without unnecessary proteins, albumin, or gelatin—enhancing purity and minimizing immunogenic risks.